Biotechnology - Chapel Hill, North Carolina, United States
KinoDyn, Inc. is a Chapel Hill-based cancer drug discovery company built around a proprietary technology using multiplexed inhibitor beads and mass spectroscopy (MIB/MS). The technology simultaneously maps and quantifies important cellular enzymes, kinases, and determines their kinome-wide response to targeted therapeutics. The MIB/MS technology is sensitive and robust enough to use on human cancer patient samples and provides a ‘first-of-its-kind' approach to discover new drugs or drug combinations for cancer therapy. We are currently focused on challenging cancers including triple negative breast cancer (TNBC), pancreatic cancer, drug-resistant leukemias and glioblastoma.